Telomere recombination requires the MUS81 endonuclease

Abstract

Telomerase-negative cells maintain their telomeres through an alternative pathway that involves DNA recombination after replication. In this pathway, the recombination endonuclease MUS81 is found to regulate telomeric recombination and maintains the length of telomeres by interacting with the telomere binding protein TRF2. Telomerase-negative cancer cells maintain their telomeres through the alternative lengthening of telomeres (ALT) pathway1,2,3. Although a growing body of evidence demonstrates that the ALT mechanism is a post-replicative telomere recombination process, molecular details of this pathway are largely unknown. Here we demonstrate that MUS81, a DNA structure specific recombination endonuclease, has a key role in the maintenance of telomeres in human ALT cells. We find that MUS81 specifically localizes to ALT-associated promyelocytic leukaemia (PML) nuclear bodies (APBs) and associates with telomeric DNA in ALT cells, which is enriched during the G2 phase of the cell cycle. Depletion of MUS81 results in the reduction of ALT-specific telomere recombination and leads to proliferation arrest of ALT cells. In addition, the endonuclease activity of MUS81 is required for recombination-based ALT cell survival, and the interaction of MUS81 with the telomeric repeat-binding factor TRF2 regulates this enzymatic activity, thereby maintaining telomere recombination. Thus, our results suggest that MUS81 is involved in the maintenance of ALT cell survival at least in part by homologous recombination of telomeres.